Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Metastatic Hepatocellular Carcinoma - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Metastatic Hepatocellular Carcinoma Report Assessment Current Treatment Practices in Metastatic Hepatocellular Carcinoma Unmet Needs in Metastatic Hepatocellular Carcinoma Market Attractiveness Market Drivers and Barriers KEY ...

January 2019 100 pages

Metastatic Hormone Refractory Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Therapies in Metastatic Hormone Refractory Prostate Cancer Metastatic Hormone Refractory Prostate Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Metastatic Hormone Refractory Prostate Cancer Report Assessment ...

January 2019 100 pages

Metastatic Prostate Cancer - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Metastatic Prostate Cancer Report Assessment Current Treatment Practices in Metastatic Prostate Cancer Unmet Needs in Metastatic Prostate Cancer Market Attractiveness Market Drivers and Barriers KEY ...

January 2019 100 pages

Metastatic Renal Cell Carcinoma (mRCC) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Metastatic Renal Cell Carcinoma (mRCC) Market Opportunities Impact of upcoming Therapies in Metastatic Renal Cell Carcinoma (mRCC) Metastatic Renal Cell Carcinoma (mRCC) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Moderate Psoriasis - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Pipeline Analysis Moderate Psoriasis Market Size and Trends Moderate Psoriasis Market Opportunities Impact of upcoming Therapies in Moderate Psoriasis Moderate Psoriasis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Gravis Pipeline Analysis Myasthenia Gravis Market Size and Trends Myasthenia Gravis Market Opportunities Impact of upcoming Therapies in Myasthenia Gravis Myasthenia Gravis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Myelofibrosis - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Myelofibrosis Pipeline Analysis Myelofibrosis Market Size and Trends Myelofibrosis Market Opportunities Impact of upcoming Therapies in Myelofibrosis Myelofibrosis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Nasopharyngeal Cancer - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Nasopharyngeal Cancer Report Assessment Current Treatment Practices in Nasopharyngeal Cancer Unmet Needs in Nasopharyngeal Cancer Market Attractiveness Market Drivers and Barriers KEY BENEFITS The ...

January 2019 100 pages

Neuroblastoma - Market Insights, Epidemiology and Market Forecast-2028

US$ 6,250.00

... Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Neuroblastoma Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake ...

January 2019 100 pages

Nicotine Addiction - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Pipeline Analysis Nicotine Addiction Market Size and Trends Nicotine Addiction Market Opportunities Impact of upcoming Therapies in Nicotine Addiction Nicotine Addiction Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Nocturia - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... in Nocturia Nocturia Pipeline Analysis Nocturia Market Size and Trends Nocturia Market Opportunities Impact of upcoming Therapies in Nocturia Nocturia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Nocturia Report ...

January 2019 100 pages

Non Alcoholic Fatty Liver Disease (NAFLD) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Non Alcoholic Fatty Liver Disease (NAFLD) Report Assessment Current Treatment Practices in Non Alcoholic Fatty Liver Disease (NAFLD) Unmet Needs in Non Alcoholic Fatty Liver Disease (NAFLD) Market ...

January 2019 100 pages

Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Non-Small Cell Lung Cancer Report Assessment Current Treatment Practices in Non-Small Cell Lung Cancer Unmet Needs in Non-Small Cell Lung Cancer Market Attractiveness Market Drivers and Barriers KEY ...

January 2019 100 pages

Nosocomial Infections - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Nosocomial Infections Report Assessment Current Treatment Practices in Nosocomial Infections Unmet Needs in Nosocomial Infections Market Attractiveness Market Drivers and Barriers KEY BENEFITS The ...

January 2019 100 pages

Primary Biliary Cirrhosis - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Primary Biliary Cirrhosis Report Assessment Current Treatment Practices in Primary Biliary Cirrhosis Unmet Needs in Primary Biliary Cirrhosis Market Attractiveness Market Drivers and Barriers KEY ...

January 2019 100 pages

Systemic Lupus Erythematosus - Epidemiology Forecast to 2028

US$ 3,250.00

... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Systemic Lupus Erythematosus Key assessments Patient Segmentation in Systemic Lupus Erythematosus Systemic Lupus Erythematosus Risk & Burden Factors driving growth in a specific Systemic Lupus Erythematosus patient population

January 2019 50 pages

Nonalcoholic Steatohepatitis (NASH) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Nonalcoholic Steatohepatitis (NASH) Report Assessment Current Treatment Practices in Nonalcoholic Steatohepatitis (NASH) Unmet Needs in Nonalcoholic Steatohepatitis (NASH) Market Attractiveness Market Drivers and Barriers KEY ...

January 2019 100 pages

Abemaciclib - Launch Insight, 2019

US$ 1,500.00

... the clients within 48 hours DelveInsight’s, “Abemaciclib, Launch Insight, 2019' report provides comprehensive Insight about the Abemaciclib's launch. The report covers all the indications for ... type and mechanism of action Detailed description of non-clinical and clinical studies for all the indications Patent ...

January 2019 50 pages

Ozanimod - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Ozanimod, Launch Insight, 2019' report provides comprehensive Insight about the Ozanimod's launch. The report covers all the indications ... market positioning of the upcoming launch of Ozanimod and will also provide the insight about how Ozanimod will evolve in the market ...

January 2019 50 pages

Epacadostat - Launch Insight, 2019

US$ 1,500.00

... the clients within 48 hours DelveInsight’s, “Epacadostat, Launch Insight, 2019' report provides comprehensive Insight about the Epacadostat's launch. The report covers all the indications ... its chemical properties, molecule type and mechanism of action Detailed description of non-clinical and clinical studies ...

January 2019 50 pages

Apalutamide - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Apalutamide, Launch Insight, 2019' report provides comprehensive Insight about the Apalutamide's launch. The report covers all the ... market positioning of the upcoming launch of Apalutamide and will also provide the insight about how Apalutamide will evolve in the market ...

January 2019 50 pages

Aducanumab - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Aducanumab, Launch Insight, 2019' report provides comprehensive Insight about the Aducanumab's launch. The report covers all the ... market positioning of the upcoming launch of Aducanumab and will also provide the insight about how Aducanumab will evolve in the market ...

January 2019 50 pages

Intepirdine - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Intepirdine, Launch Insight, 2019' report provides comprehensive Insight about the Intepirdine's launch. The report covers all the ... market positioning of the upcoming launch of Intepirdine and will also provide the insight about how Intepirdine will evolve in the market ...

January 2019 50 pages

Lampalizumab - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Lampalizumab, Launch Insight, 2019' report provides comprehensive Insight about the Lampalizumab's launch. The report covers all the ... market positioning of the upcoming launch of Lampalizumab and will also provide the insight about how Lampalizumab will evolve in the ...

January 2019 50 pages

MPC-150-IM - Launch Insight, 2019

US$ 1,500.00

... “MPC-150-IM, Launch Insight, 2019' report provides comprehensive Insight about the MPC-150-IM's launch. The report covers all the indications for which the MPC-150-IM is ... market positioning of the upcoming launch of MPC-150-IM and will also provide the insight about how MPC-150-IM will evolve in the market ...

January 2019 50 pages

Elagolix - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Elagolix, Launch Insight, 2019' report provides comprehensive Insight about the Elagolix's launch. The report covers all the indications ... market positioning of the upcoming launch of Elagolix and will also provide the insight about how Elagolix will evolve in the market ...

January 2019 50 pages

Epidiolex - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Epidiolex, Launch Insight, 2019' report provides comprehensive Insight about the Epidiolex's launch. The report covers all the ... market positioning of the upcoming launch of Epidiolex and will also provide the insight about how Epidiolex will evolve in the market ...

January 2019 50 pages

Emicizumab - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Emicizumab, Launch Insight, 2019' report provides comprehensive Insight about the Emicizumab's launch. The report covers all the ... market positioning of the upcoming launch of Emicizumab and will also provide the insight about how Emicizumab will evolve in the market ...

January 2019 50 pages

Tezacaftor (VX-661) + Ivacaftor - Launch Insight, 2019

US$ 1,500.00

... of market positioning of the upcoming launch of Tezacaftor (VX-661) + Ivacaftor and will also provide the insight about how Tezacaftor (VX-661) + Ivacaftor will evolve in the market as well ...

January 2019 50 pages

Tremelimumab - Launch Insight, 2019

US$ 1,500.00

... the clients within 48 hours DelveInsight’s, “Tremelimumab, Launch Insight, 2019' report provides comprehensive Insight about the Tremelimumab's launch. The report covers all the indications for ... type and mechanism of action Detailed description of non-clinical and clinical studies for all the indications ...

January 2019 50 pages

Lanadelumab - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Lanadelumab, Launch Insight, 2019' report provides comprehensive Insight about the Lanadelumab's launch. The report covers all the ... market positioning of the upcoming launch of Lanadelumab and will also provide the insight about how Lanadelumab will evolve in the market ...

January 2019 50 pages

AR101 - Launch Insight, 2019

US$ 1,500.00

... the clients within 48 hours DelveInsight’s, “AR101, Launch Insight, 2019' report provides comprehensive Insight about the AR101's launch. The report covers all the indications ... of market positioning of the upcoming launch of AR101 and will also provide the insight about how AR101 will evolve in the market as ...

January 2019 50 pages

Brexanolone - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Brexanolone, Launch Insight, 2019' report provides comprehensive Insight about the Brexanolone's launch. The report covers all the ... market positioning of the upcoming launch of Brexanolone and will also provide the insight about how Brexanolone will evolve in the market ...

January 2019 50 pages

Acalabrutinib - Launch Insight, 2019

US$ 1,500.00

... within 48 hours DelveInsight’s, “Acalabrutinib, Launch Insight, 2019' report provides comprehensive Insight about the Acalabrutinib's launch. The report covers all the ... market positioning of the upcoming launch of Acalabrutinib and will also provide the insight about how Acalabrutinib will evolve in the ...

January 2019 50 pages

NuThrax - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “NuThrax, Launch Insight, 2019' report provides comprehensive Insight about the NuThrax's launch. The report covers all the indications ... of market positioning of the upcoming launch of NuThrax and will also provide the insight about how NuThrax will evolve in the market ...

January 2019 50 pages

Upadacitinib - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Upadacitinib, Launch Insight, 2019' report provides comprehensive Insight about the Upadacitinib's launch. The report covers all the ... market positioning of the upcoming launch of Upadacitinib and will also provide the insight about how Upadacitinib will evolve in the ...

January 2019 50 pages

Siponimod - Launch Insight, 2019

US$ 1,500.00

... clients within 48 hours DelveInsight’s, “Siponimod, Launch Insight, 2019' report provides comprehensive Insight about the Siponimod's launch. The report covers all the ... market positioning of the upcoming launch of Siponimod and will also provide the insight about how Siponimod will evolve in the market ...

January 2019 50 pages

Allergic Rhinitis - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Rhinitis Pipeline Analysis Allergic Rhinitis Market Size and Trends Allergic Rhinitis Market Opportunities Impact of upcoming Therapies in Allergic Rhinitis Allergic Rhinitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Alzheimer’s disease (AD) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Alzheimer’s disease (AD) Report Assessment Current Treatment Practices in Alzheimer’s disease (AD) Unmet Needs in Alzheimer’s disease (AD) Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

January 2019 100 pages

Anal Cancer  - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... in Anal Cancer Anal Cancer Pipeline Analysis Anal Cancer Market Size and Trends Anal Cancer Market Opportunities Impact of upcoming Therapies in Anal Cancer Anal Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Anal ...

January 2019 100 pages

Asthma - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Asthma Therapeutic Approaches in Asthma Asthma Pipeline Analysis Asthma Market Size and Trends Asthma Market Opportunities Impact of upcoming Therapies in Asthma Asthma Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Asthma ...

January 2019 100 pages

Asthma -Epidemiology Forecast to 2028

US$ 3,250.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Asthma Key assessments Patient Segmentation in Asthma Asthma Risk & Burden Factors driving growth in a specific Asthma patient population

January 2019 50 pages

Atopic Dermatitis (AD) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Atopic Dermatitis (AD) Report Assessment Current Treatment Practices in Atopic Dermatitis (AD) Unmet Needs in Atopic Dermatitis (AD) Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

January 2019 100 pages

Atrial Fibrillation - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Pipeline Analysis Atrial Fibrillation Market Size and Trends Atrial Fibrillation Market Opportunities Impact of upcoming Therapies in Atrial Fibrillation Atrial Fibrillation Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Attention-deficit/hyperactivity disorder (ADHD) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Therapies in Attention-deficit/hyperactivity disorder (ADHD) Attention-deficit/hyperactivity disorder (ADHD) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Attention-deficit/hyperactivity disorder (ADHD) Report Assessment ...

January 2019 100 pages

Benign prostatic hyperplasia (BPH) - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Pipeline Analysis Benign prostatic hyperplasia (BPH) Market Size and Trends Benign prostatic hyperplasia (BPH) Market Opportunities Impact of upcoming Therapies in Benign prostatic hyperplasia (BPH) Benign prostatic hyperplasia (BPH) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation ...

January 2019 100 pages

Bile Duct Cancer  - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... Duct Cancer Pipeline Analysis Bile Duct Cancer Market Size and Trends Bile Duct Cancer Market Opportunities Impact of upcoming Therapies in Bile Duct Cancer Bile Duct Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Bile Duct Cancer  -Epidemiology Forecast to 2028

US$ 3,250.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bile Duct Cancer Key assessments Patient Segmentation in Bile Duct Cancer Bile Duct Cancer Risk & Burden Factors driving growth in a specific Bile Duct Cancer patient population

January 2019 50 pages

Bladder cancer - Market Insight, Epidemiology and Market Forecast - 2028

US$ 6,250.00

... cancer Bladder cancer Pipeline Analysis Bladder cancer Market Size and Trends Bladder cancer Market Opportunities Impact of upcoming Therapies in Bladder cancer Bladder cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...

January 2019 100 pages

Bladder cancer -Epidemiology Forecast to 2028

US$ 3,250.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bladder cancer Key assessments Patient Segmentation in Bladder cancer Bladder cancer Risk & Burden Factors driving growth in a specific Bladder cancer patient population

January 2019 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1